Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain
Chronic Low Back Pain
About this trial
This is an interventional treatment trial for Chronic Low Back Pain focused on measuring bicifadine, chronic low back pain
Eligibility Criteria
Main Inclusion Criteria: Patients with low back pain assessed as Class 1, Class 2 or Class 3 according to the Quebec Task Force Classification for Spinal Disorders and without detectable leg weakness on neurological examination. Patients must have required on average daily analgesics for the treatment of low back pain for at least 3 months prior to dosing. Main Exclusion Criteria: Patients may not have moderate or severe pain in a location other than the lower back (with the exception of radiation to the lower extremity). Patients must not have had lower back surgery within 6 months prior to baseline, nor epidural corticosteroid injections within 3 months prior to baseline. Patients may not have an unstable medical condition.